ArticleInternational journal of applied & basic medical research
Increasing Prevalence of
Article in International journal of applied & basic medical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 30 citations in OpenAlex.
- Prevalence and molecular characterization of colistin-resistant gram-negative bacteria from a tertiary care hospital in Eastern India.BMC microbiology · 2026Article
- Detection and prevalence of theIranian journal of microbiology · 2026Article
- Article
- The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities.Hematology reports · 2025Review
- High Rates of Antimicrobial Resistance and Emergence of High-Risk Clones in Community-Acquired Uropathogenic Escherichia coli.MicrobiologyOpen · 2025Article
- High proportions of multidrug-resistant Klebsiella pneumoniae isolates in community-acquired infections, Brazil.Scientific reports · 2025Article
- Article
- Extended-spectrum beta-lactamase-producingMicrobiology spectrum · 2024Article
- Antimicrobial Susceptibility Profiles ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024Article
- Molecular characterization and antibiotic resistance profile of ESBL-producingVeterinary world · 2023Article
- Sequence-Specific Gene Silencing of acrA in the Multi-drug Efflux System AcrAB Induces Sensitivity in Drug-Resistant Klebsiella pneumoniae.Molecular biotechnology · 2023Article
- Characteristics of community-acquired carbapenem-resistant Enterobacterales.The Journal of antimicrobial chemotherapy · 2022Article
- Multiresistant Enterobacteriaceae in yellow-legged gull chicks in their first weeks of life.Ecology and evolution · 2022Article
- Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India.Scientific reports · 2022Article
- Prevalence and Molecular Characterization of Extended Spectrum β-Lactamase and Carbapenemase-ProducingInfection and drug resistance · 2022Article
- Antimicrobial Resistance Situational Analysis 2019-2020: Design and Performance for Human Health Surveillance in Uganda.Tropical medicine and infectious disease · 2021Review
- Colonization with selected antibiotic resistant bacteria among a cohort of Sri Lankan university students.BMC infectious diseases · 2021Article
- Whole-Genome Sequencing of Extended-Spectrum Beta-Lactamase-ProducingFrontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIncreasing prevalence of community-acquired infections (CAIs) due to MATERIALS AND
methodsA total of 1275 strains of
resultsAmong 1275
conclusionThe present study showed the increasing the prevalence of ESBL including CTX-M variety, carbapenemase production by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.